Amgen To Present At The Morgan Stanley Global Healthcare Conference
THOUSAND OAKS, Calif., Sept. 6, 2013
THOUSAND OAKS, Calif., Sept. 6, 2013 /PRNewswire/ --Amgen (NASDAQ: AMGN) will
participate in the Morgan Stanley Global Healthcare Conference on Wednesday,
Sept. 11, 2013, at the Grand Hyatt New York in New York City, beginning at
8:35 a.m. Eastern Daylight Time. Robert A. Bradway, chairman and chief
executive officer at Amgen, will present at the conference. Live audio of the
presentation can be accessed from the Events Calendar on Amgen's website,
www.amgen.com, under Investors. A replay of the webcast will also be available
on Amgen's website for 90 days following the event.
Amgen is committed to unlocking the potential of biology for patients
suffering from serious illnesses by discovering, developing, manufacturing and
delivering innovative human therapeutics. This approach begins by using tools
like advanced human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its biologics
manufacturing expertise to strive for solutions that improve health outcomes
and dramatically improve people's lives. A biotechnology pioneer since 1980,
Amgen has grown to be the world's largest independent biotechnology company,
has reached millions of patients around the world and is developing a pipeline
of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on
CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)
Press spacebar to pause and continue. Press esc to stop.